Cite
HARVARD Citation
Bagot, M. et al. (n.d.). IPH4102 in relapsed/refractory cutaneous T cell lymphoma (CTCL): Results of the first-in-human multicenter phase 1 study. European journal of cancer. pp. S29-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bagot, M. et al. (n.d.). IPH4102 in relapsed/refractory cutaneous T cell lymphoma (CTCL): Results of the first-in-human multicenter phase 1 study. European journal of cancer. pp. S29-. [Online].